Wasatch BioLabs and Oxford Nanopore Team Up to Accelerate Methylation Sequencing Towards Clinical Use
- Methylation
- Metagenomics
- Whole genome
- cfDNA
- High-throughput
November 1 2024
Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease | Oxford Nanopore Technologies
- Methylation
- Epigenetics
- Clinical research
- Direct analysis
- High-throughput
- Human genomics
November 27 2024
Oxford Nanopore at ASHG 2021: find out how you can use nanopore technology to gain comprehensive, scalable, accurate insights in human genomics
- Methylation
- Human genomics
- Structural variation
- Assembly
October 19 2021
Oxford Nanopore and Genomics England announce new strategic research project to resolve undiagnosed rare disease cases
- Methylation
- PromethION
November 1 2023
Interview: Using PromethION for Cancer, Collaborations and more
- Methylation
- Interview
- PromethION
- Human genomics
- Cancer research
- Structural variation
June 25 2021
Interview: Resolving complex genomic structures and regulation patterns in cervical cancer
- Methylation
- Cancer research
- Epigenetics
May 12 2023
Interview: The PromethION Experts at VIB
- Methylation
- Interview
- PromethION
- Human genomics
- Structural variation
July 2 2021
Innovations with ultra-long reads
- Methylation
- Long-read
- PromethION
- London Calling
- Structural variation
- Phasing
June 18 2021